Typhoid fever, also known as enteric fever , is a disease caused by a bacterium called Salmonella enterica serotype Typhi (Salmonella Typhi). Although it can be life-threatening, there is a less than 1% death rate among infected persons in the United States. Infected persons can develop sustained fever of up to 104F (40C), weakness, stomach pain, and headache. A rash (rose spots) may accompany the infection. According to the Centers for Disease Control and Prevention (CDC), there are about 300 cases of typhoid fever in the United States each year. The majority are in persons returning from international travels. There are about 20 million cases of typhoid fever causing 200 000 deaths worldwide yearly. The August 26, 2009, issue of JAMA includes an article about antibiotic resistance in typhoid fever.
Salmonella Typhi bacteria are shed in the stool of infected persons. Transmission of typhoid fever is usually through food or drinks that are handled or served after poor hand washing or when contaminated sewage gets into drinking or hand-washing water. About 5% of sick persons recover from the infection but continue to carry the bacteria in their bodies and excrete it in their stool and urine. These people are known as carriers. Mary Mallon (aka Typhoid Mary) was the first person to be identified as a healthy carrier in the United States. She may have infected as many as 53 people during her career as a cook in New York City but never acknowledged the possibility that she could be a typhoid carrier. Typhoid researcher George Soper originally published findings about Mallon in the June 15, 1907, issue of JAMA. The term "Typhoid Mary" is now used to refer to any carrier of a dangerous disease who has become a danger to the public because of a refusal to take proper precautions.
Typhoid fever is preventable through vaccination prior to traveling to areas where typhoid is common, and careful eating while there. The CDC recommends the following food and drink policy for travelers: "boil it, cook it, peel it, or forget it." CDC recommendations include drinking only bottled water or water that has been boiled for at least a minute, avoiding ice, eating well-cooked foods, avoiding raw vegetables and fruits that cannot be peeled, and avoiding foods and drinks from street vendors.
The only definitive way to diagnose typhoid fever is by isolating the causative bacteria from the patient, most often from blood, but also from urine, stool, or bone marrow.
Treatment with appropriate antibiotics can prevent complications. Treatment with antibiotics usually results in improvement within several days. However, in untreated disease, symptoms can continue for weeks or months, with as many as 20% dying from the disease. Recent development of antibiotic resistance in parts of the world is a cause for concern.
Centers for Disease Control and Prevention
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/files/typhoid_fever_FAQ.pdf
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/typhoidfever_t.htm
http://www.cdc.gov/vaccines/vpd-vac/typhoid/downloads/typhoid-travelers-prevent-2004.pdf
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on inappropriate use of antibiotics was published in the August 19, 2009, issue.
Source: Centers for Disease Control and Prevention
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
TOPIC: INFECTIOUS DISEASES
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.